Enhanced Liver Fibrosis (ELF™) Test Gauges Likelihood of Disease Progression; Expands Labcorp’s Testing Options for Nonalcoholic Fatty Liver Disease The ELF test provides a numeric score to people ...

The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...

Combining retina scanning with liver stiffness assessment offers a promising, efficient approach to identify advanced fibrosis and MASLD in type 2 diabetes patients. Study: Screening for advanced ...

Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin).

Using human induced pluripotent stem cells, researchers have built a miniature 3D liver model that replicates the critical interaction between hepatocytes and stellate cells. As chronic liver disease ...

At present, transient elastography and the serum marker FibroTest are the most intensively evaluated non-invasive methods for the assessment of liver fibrosis. The results of the present study for ...

In patients with metabolic abnormal fatty liver disease (MASLD), if the blood test index is low but the cirrhosis is high, the actual liver fibrosis is more severe and the risk of liver complications ...

Through these partnerships the company will provide advanced diagnostic testing services to patients with Metabolic Dysfunction–associated Steatohepatitis (MASH), supporting more precise disease ...

Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be caused by a variety of factors, including metabolic dysfunction-associated ...